viviancui
Lv21
180 积分
2022-03-01 加入
-
New immune cell engagers for cancer immunotherapy
6小时前
已完结
-
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis
3个月前
已完结
-
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
3个月前
已完结
-
Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems
3个月前
已完结
-
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
3个月前
已完结
-
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial
3个月前
已完结
-
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
3个月前
已完结
-
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
3个月前
已完结
-
Tissue-Specific Cadherin CDH17 Is a Useful Marker of Gastrointestinal Adenocarcinomas With Higher Sensitivity Than CDX2
3个月前
已完结
-
Heterotypic trans-Interaction of LI- and E-Cadherin and Their Localization in Plasmalemmal Microdomains
3个月前
已完结